| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.2 | 0.3 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.3 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |